@article{731ecb71155c4269a89a4afc6c156377,
title = "Accumulation of succinyl coenzyme a perturbs the methicillin-resistant staphylococcus aureus (Mrsa) succinylome and is associated with increased susceptibility to beta-lactam antibiotics",
abstract = "Penicillin binding protein 2a (PBP2a)-dependent resistance to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus (MRSA) is regulated by the activity of the tricarboxylic acid (TCA) cycle via a poorly understood mechanism. We report that mutations in sucC and sucD, but not other TCA cycle enzymes, negatively impact β-lactam resistance without changing PBP2a expression. Increased intracellular levels of succinyl coenzyme A (succinyl-CoA) in the sucC mutant significantly perturbed lysine succinylation in the MRSA proteome. Suppressor mutations in sucA or sucB, responsible for succinyl-CoA biosynthesis, reversed sucC mutant phenotypes. The major autolysin (Atl) was the most succinylated protein in the proteome, and increased Atl succinylation in the sucC mutant was associated with loss of autolytic activity. Although PBP2a and PBP2 were also among the most succinylated proteins in the MRSA proteome, peptidoglycan architecture and cross-linking were unchanged in the sucC mutant. These data reveal that perturbation of the MRSA succinylome impacts two interconnected cell wall phenotypes, leading to repression of autolytic activity and increased susceptibility to β-lactam antibiotics.",
keywords = "Antibiotic resistance, Beta-lactams, MRSA, Succinyl-CoA, Succinylome, TCA cycle",
author = "Christopher Campbell and Claire Fingleton and Zeden, {Merve S.} and Emilio Bueno and Gallagher, {Laura A.} and Dhananjay Shinde and Jongsam Ahn and Olson, {Heather M.} and Fillmore, {Thomas L.} and Adkins, {Joshua N.} and Fareha Razvi and Bayles, {Kenneth W.} and Fey, {Paul D.} and Thomas, {Vinai C.} and Felipe Cava and Clair, {Geremy C.} and O{\textquoteright}gara, {James P.}",
note = "Funding Information: C.C., C.F., M.S.Z., L.A.G., and J.P.O. were supported by grants from the Health Research Board (HRA-POR-2015-1158 and ILP-POR-2019-102) (www.hrb.ie), the Irish Research Council (GOIPG/2014/763 and GOIPG/2016/36) (www.research.ie), and Science Foundation Ireland (19/FFP/6441) (www.sfi.ie). E.B. and F.C. were supported by a grant from Svenska Forskningsr{\aa}det Formas. G.C., H.M.O., T.L.F., and J.A. were supported by the IARPA FunGCAT program, NIGMS grant GM103493, and Department of Energy contract DE-AC05-76RLO 1830. K.W.B., P.D.F., V.C.T., D.S., J.N.A., and F.R. were supported by National Institute of Allergy and Infectious Diseases (NIAID) grant P01-AI83211. K.W.B. and J.N.A. were supported by NIAID grant R01-AI125589. D.S. and V.C.T . were supported by grant NIAID R01AI125588. Publisher Copyright: {\textcopyright} 2021 Campbell et al.",
year = "2021",
month = jun,
doi = "10.1128/mBio.00530-21",
language = "English (US)",
volume = "12",
journal = "mBio",
issn = "2161-2129",
publisher = "American Society for Microbiology",
number = "3",
}